Loading...

Prospective exosome‐focused translational research for afatinib study of non‐small cell lung cancer patients expressing EGFR (EXTRA study)

Patients with EGFR‐mutated non‐small cell lung cancer (NSCLC) exhibit resistance to EGFR‐tyrosine kinase inhibitors (TKIs) within 9–14 months of therapy. Recently, EGFR‐mutated NSCLC has demonstrated the potential for heterogeneity; therefore, the manner of clonal heterogeneity may impact the durati...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorac Cancer
Main Authors: Okuma, Yusuke, Morikawa, Kei, Tanaka, Hisashi, Yokoyama, Takuma, Itani, Hidetoshi, Horiuchi, Kazuya, Nakagawa, Hideyuki, Takahashi, Nobumasa, Bessho, Akihiro, Soejima, Kenzo, Kishi, Kazuma, Togashi, Akira, Kanai, Yae, Ueda, Koji, Horimoto, Katsuhisa, Matsutani, Noriyuki, Seki, Nobuhiko
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons Australia, Ltd 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360199/
https://ncbi.nlm.nih.gov/pubmed/30536780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12923
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!